TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,278,684
|
1,204,856
|
779,672 |
| Financial expenses |
964
|
269
|
57 |
| Earnings before taxes |
50,433
|
48,019
|
34,200 |
| EBITDA |
46,152
|
44,687
|
33,407 |
| Total assets |
250,536
|
327,496
|
298,968 |
| Current assets |
249,398
|
327,322
|
298,722 |
| Current liabilities |
131,518
|
214,806
|
203,591 |
| Equity capital |
91,524
|
85,532
|
66,549 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
123
|
110
|
115 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.5%
|
26.1%
|
22.3% |
| Turnover per employee |
10,396
|
10,953
|
6,780 |
| Profit as a percentage of turnover |
3.9%
|
4.0%
|
4.4% |
| Return on assets (ROA) |
20.5%
|
14.7%
|
11.5% |
| Current ratio |
189.6%
|
152.4%
|
146.7% |
| Return on equity (ROE) |
55.1%
|
56.1%
|
51.4% |
| Change turnover |
113,680
|
421,168
|
153,911 |
| Change turnover % |
10%
|
54%
|
25% |
| Chg. No. of employees |
13
|
-5
|
9 |
| Chg. No. of employees % |
12%
|
-4%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.